Case descriptions

Ando supports VAR2 Pharmaceuticals in advancing preclinical development of VAR2CSA-toxin-conjugate

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. The most advanced drug candidate is a recombinant protein conjugated with a toxin.

Ando supports the company in defining their bioanalytical strategy, bioanalytical assay requirements and external partners, thereby, allowing further candidate characterization and toxicological investigations for preparation of the first clinical trial.

ando-logo-01.png

Nordre Strandvej 119D,
3150, Hellebaek, Denmark
+45 2568 3668
anke.domdey@andobio.com

Search